BNP Paribas Asset Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-143,196
Closed -$8.11M 976
2018
Q2
$8.11M Buy
143,196
+17,597
+14% +$893K 0.07% 385
2018
Q1
$5.31M Sell
125,599
-42,740
-25% -$1.84M 0.04% 469
2017
Q4
$9.01M Buy
168,339
+1,354
+0.8% +$71.5K 0.08% 360
2017
Q3
$7.45M Buy
166,985
+11,931
+8% +$544K 0.06% 406
2017
Q2
$7.54M Buy
155,054
+2,220
+1% +$131K 0.07% 393
2017
Q1
$11.1M Buy
152,834
+14,537
+11% +$961K 0.1% 284
2016
Q4
$7.91M Buy
138,297
+15,230
+12% +$1.4M 0.08% 360
2016
Q3
$15.8M Buy
123,067
+38,042
+45% +$4.87M 0.13% 203
2016
Q2
$10.6M Buy
+85,025
New +$9.78M 0.09% 308

Other funds holding ELGX

BNP Paribas Asset Management's ELGX Position: Q3 2018 in Review

BNP Paribas Asset Management sold out of Endologix Inc (ELGX) in Q3 2018, closing a stake of 143,196 shares — an estimated $8.11M sold.

BNP Paribas Asset Management first reported a position in ELGX in Q2 2016 and held it in 9 quarters. The position peaked at $15.8M in Q3 2016. 100 funds tracked by Wall St. Rank hold ELGX as of Q3 2018.

  • BNP Paribas Asset Management reported no remaining Endologix Inc position as of Q3 2018 after selling out during the quarter.
  • BNP Paribas Asset Management sold 143,196 Endologix Inc shares in Q3 2018, an estimated $8.11M.
  • BNP Paribas Asset Management first reported a position in Endologix Inc in Q2 2016 and held it in 9 quarters.
  • BNP Paribas Asset Management's Endologix Inc position peaked at $15.8M in Q3 2016.
  • 100 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2018.

Based on BNP Paribas Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.